المؤلفون: Igor Puzanov, Richard Miller, Jason Luke, Jeffrey Sosman, Thomas Marron, Brett Hughes, Abhishek Tripathi, Mehrdad Mobasher, Craig Hill, Shenshen Hu, Suresh Mahabhashyam, Kristen Marrone, Jaime Merchan, James Janc, Jenny Rudnick

المصدر: Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)

مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2051-1426

URL الوصول: https://doaj.org/article/03e6bccc86e0415f8d78ce6f1694289c

المؤلفون: Iris de Weerdt, Tom Hofland, Renate de Boer, Johan A. Dobber, Julie Dubois, Denise van Nieuwenhuize, Mehrdad Mobasher, Fransien de Boer, Mels Hoogendoorn, Gerjo A. Velders, Marjolein van der Klift, Ester B.M. Remmerswaal, Frederike J. Bemelman, Carsten U. Niemann, Sabina Kersting, Mark-David Levin, Eric Eldering, Sanne H. Tonino, Arnon P. Kater

المصدر: Blood Advances, Vol 3, Iss 17, Pp 2642-2652 (2019)

مصطلحات موضوعية: Specialties of internal medicine, RC581-951

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S247395292030015X; https://doaj.org/toc/2473-9529

URL الوصول: https://doaj.org/article/9b70facd4d2e4144a9ac742f72e1a6b0

المؤلفون: Joshua Brody, Stephen Willingham, Richard Miller, Thomas Marron, Gerard Criner, Mehrdad Mobasher, Craig Hill, Shenshen Hu, Suresh Mahabhashyam

المصدر: Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)

مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2051-1426

URL الوصول: https://doaj.org/article/38d0ec6638e449f58996a29a7eec3d1d

المؤلفون: Stephan Stilgenbauer, Franck Morschhauser, Clemens-Martin Wendtner, Guillaume Cartron, Michael Hallek, Barbara Eichhorst, Mark F. Kozloff, Thomas Giever, Gerard Lozanski, Yanwen Jiang, Huang Huang, Daniela Soriano Pignataro, William Schary, Kathryn Humphrey, Mehrdad Mobasher, Gilles Salles

المصدر: Haematologica, Vol 106, Iss 11 (2020)

مصطلحات موضوعية: Diseases of the blood and blood-forming organs, RC633-647.5

وصف الملف: electronic resource

Relation: https://haematologica.org/article/view/10070; https://doaj.org/toc/0390-6078; https://doaj.org/toc/1592-8721

URL الوصول: https://doaj.org/article/1a1f8f69ec2f440c9474f9d204dd342e

المؤلفون: Sabina Kersting, Julie Dubois, Kazem Nasserinejad, Johan A Dobber, Clemens Mellink, Anne-Marie F van der Kevie-Kersemaekers, Ludo M Evers, Fransien de Boer, Harry R Koene, John Schreurs, Marjolein van der Klift, Gerjo A Velders, Ellen van der Spek, Hanneke M van der Straaten, Mels Hoogendoorn, Michel van Gelder, Eduardus F M Posthuma, Hein P J Visser, Ilse Houtenbos, Cecile A M Idink, Djamila E Issa, Ellen C Dompeling, Henk C T van Zaanen, Hendrik Veelken, Henriette Levenga, Lidwine W Tick, Wim E Terpstra, Sanne H Tonino, Michelle Boyer, Mehrdad Mobasher, Mark-David Levin, Arnon P Kater

المساهمون: Human Genetics, ARD - Amsterdam Reproduction and Development, Clinical Haematology, AII - Cancer immunology, CCA - Cancer Treatment and Quality of Life, Experimental Immunology, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Hematologie (9), Hematology

المصدر: The Lancet Haematology, 9(3), e190-e199. Lancet Publishing Group
The Lancet Haematology, 9(3), E190-E199. ELSEVIER SCI LTD

مصطلحات موضوعية: Male, Sulfonamides, Adolescent, FLOW, MINIMAL RESIDUAL DISEASE, Hematology, QUANTIFICATION, Antibodies, Monoclonal, Humanized, Bridged Bicyclo Compounds, Heterocyclic, GUIDELINES, DIAGNOSIS, Leukemia, Lymphocytic, Chronic, B-Cell, MRD, CHLORAMBUCIL, Antineoplastic Combined Chemotherapy Protocols, Humans, Female, RITUXIMAB, CLL

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0986e715312f80218fa9f8521d8b97ab
https://doi.org/10.1016/s2352-3026(22)00034-5

المؤلفون: Yanwen Jiang, Stephan Stilgenbauer, Mehrdad Mobasher, Gilles Salles, Barbara Eichhorst, William Schary, Michael Hallek, Franck Morschhauser, Daniela Soriano Pignataro, Huang Huang, Clemens-Martin Wendtner, Gerard Lozanski, Kathryn Humphrey, Guillaume Cartron, Thomas Giever, Mark Kozloff

المصدر: Haematologica

مصطلحات موضوعية: Bendamustine, medicine.medical_specialty, Neutropenia, Antibodies, Monoclonal, Humanized, Gastroenterology, Article, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Obinutuzumab, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Bendamustine Hydrochloride, Humans, Sulfonamides, Chlorambucil, Venetoclax, business.industry, Hematology, medicine.disease, Bridged Bicyclo Compounds, Heterocyclic, Leukemia, Lymphocytic, Chronic, B-Cell, 3. Good health, chemistry, Tolerability, 030220 oncology & carcinogenesis, Ven, Rituximab, business, 030215 immunology, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fbd4b6167be804d13469413772f4ad6
http://europepmc.org/articles/PMC8561296

المؤلفون: Christian Tomaszewski, William B. Jones, Mehrdad Mobasher, James W. Janc, Richard A. Miller, Jorge Robles, Miriam L Cameron, Gerard J. Criner, Shenshen Hu, Stephen Willingham, Pramod Guru, Long Kwei, Philippe R. Bauer, Michael F. Waters, Suresh Mahabhashyam, Haider Mashhedi, Julián Olalla Sierra, Jenny A. Rudnick, J. Scott Overcash

مصطلحات موضوعية: biology, business.industry, medicine.medical_treatment, Immunotherapy, medicine.anatomical_structure, Immune system, Immunoglobulin class switching, Immunity, Immunology, Clinical endpoint, biology.protein, Medicine, Antibody, business, Adverse effect, B cell

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::72828493e8eb39cba2f97205aef7219a
https://doi.org/10.1101/2021.09.13.21263406

المؤلفون: Richard K. Miller, Suresh Mahabhashyam, Thomas U. Marron, Joshua Brody, Shenshen Hu, Mehrdad Mobasher, Craig M. Hill, Stephen Willingham, Gerard J. Criner

المصدر: Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)

مصطلحات موضوعية: biology, business.industry, medicine.medical_treatment, Cancer, Immunotherapy, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, lcsh:RC254-282, Asymptomatic, medicine.anatomical_structure, Immune system, Immunoglobulin class switching, Immunology, medicine, biology.protein, Antibody, medicine.symptom, business, B cell, CD8

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02a03a05b49554e1f54e5fe725d70e22
https://doi.org/10.1136/jitc-2020-sitc2020.0325

المؤلفون: Haider Mashhedi, Jenny A. Rudnick, Stephen Willingham, Suresh Mahabhashyam, Andrew Hotson, Barbara Daine-Matsuoka, William B. Jones, Craig M. Hill, Richard A. Miller, Joseph J. Buggy, Joshua Brody, Gerard J. Criner, Mehrdad Mobasher, Jessica Hsieh, Thomas U. Marron, Shenshen Hu, Emily Piccione

مصطلحات موضوعية: biology, business.industry, medicine.medical_treatment, Immunotherapy, Adenosine, Immune system, medicine.anatomical_structure, Immunoglobulin class switching, Immunology, biology.protein, Medicine, Antibody, business, Memory B cell, Adjuvant, B cell, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::96703dadfeb733be3e52521085d3231e
https://doi.org/10.1101/2020.09.10.20191486

المؤلفون: Ellen Ingalla, Deepak Sampath, Franck Morschhauser, Kylie D. Mason, Guillaume Cartron, Martine E.D. Chamuleau, Arijit Sinha, Divya Samineni, Edith Szafer-Glusman, Constantine S. Tam, Carla Casulo, Andre Goy, Pieternella J. Lugtenburg, Christian Klein, Steven Le Gouill, Adam M. Petrich, Mehrdad Mobasher, Andrew D. Zelenetz, Gilles Salles, Hervé Tilly, Sylvia Herter, Martin Kornacker, Laurie H. Sehn

المساهمون: Hematology, CCA - Cancer Treatment and quality of life, Memorial Sloane Kettering Cancer Center [New York], Centre Hospitalier Lyon Sud [CHU - HCL] (CHLS), Hospices Civils de Lyon (HCL), The Royal Melbourne Hospital, University of Rochester Medical Center (URMC), Centre hospitalier universitaire de Nantes (CHU Nantes), BC Cancer Agency (BCCRC), Centre de Lutte Contre le Cancer Henri Becquerel Normandie Rouen (CLCC Henri Becquerel), Service d'hématologie et oncologie médicale, Université Montpellier 1 (UM1)-Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Hôpital Lapeyronie-Université de Montpellier (UM), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), VU University Medical Center [Amsterdam], Hackensack University Medical Center [Hackensack], University of Melbourne, Erasmus University Medical Center [Rotterdam] (Erasmus MC), Abbvie Inc. [North Chicago], Roche Products Ltd, Genentech, Inc. [San Francisco], Roche Innovation Center Zurich, Genentech, Inc., F. Hoffmann-La Roche [Basel], Groupe de Recherche sur les formes Injectables et les Technologies Associées - ULR 7365 (GRITA), Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)

المصدر: Blood, 133(18), 1964-1976. American Society of Hematology
Blood
Blood, 2019, 133 (18), pp.1964-1976. ⟨10.1182/blood-2018-11-880526⟩
Blood, American Society of Hematology, 2019, 133 (18), pp.1964-1976. ⟨10.1182/blood-2018-11-880526⟩
Zelenetz, A D, Salles, G, Mason, K D, Casulo, C, le Gouill, S, Sehn, L H, Tilly, H, Cartron, G, Chamuleau, M E D, Goy, A, Tam, C S, Lugtenburg, P J, Petrich, A M, Sinha, A, Samineni, D, Herter, S, Ingalla, E, Szafer-Glusman, E, Klein, C, Sampath, D, Kornacker, M, Mobasher, M & Morschhauser, F 2019, ' Venetoclax plus R-or G-CHOP in non-Hodgkin lymphoma: Results from the CAVALLI phase 1b trial ', Blood, vol. 133, no. 18, pp. 1964-1976 . https://doi.org/10.1182/blood-2018-11-880526

مصطلحات موضوعية: Male, Oncology, Follicular lymphoma, CHOP, MESH: Antineoplastic combined chemotherapy protocols/therapeutic use, Bridged bicyclo compounds, Heterocyclic/therapeutic use, Lymphoma, Non-Hodgkin/drug therapy, Sulfonamides/therapeutic use, Biochemistry, chemistry.chemical_compound, 0302 clinical medicine, Obinutuzumab, immune system diseases, hemic and lymphatic diseases, Antineoplastic Combined Chemotherapy Protocols, B-cell lymphoma, Sulfonamides, 0303 health sciences, Lymphoma, Non-Hodgkin, [SDV.MHEP.HEM]Life Sciences [q-bio]/Human health and pathology/Hematology, Hematology, Middle Aged, [SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciences, 3. Good health, Vincristine, 030220 oncology & carcinogenesis, [SDV.IMM]Life Sciences [q-bio]/Immunology, Female, Rituximab, medicine.drug, medicine.medical_specialty, Maximum Tolerated Dose, Immunology, [SDV.CAN]Life Sciences [q-bio]/Cancer, Antibodies, Monoclonal, Humanized, Disease-Free Survival, 03 medical and health sciences, Internal medicine, medicine, Humans, Cyclophosphamide, Aged, 030304 developmental biology, business.industry, Venetoclax, Cell Biology, Bridged Bicyclo Compounds, Heterocyclic, medicine.disease, chemistry, Doxorubicin, Prednisone, business, Diffuse large B-cell lymphoma

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45edbe7d7ecd20cef61fcc3b7604581d
https://hdl.handle.net/1765/117144

المؤلفون: Stephan Stilgenbauer, Katell Le Du, Michael Hallek, Sue Robinson, Anna M. Liberati, Liliya Sivcheva, Javier Pinilla-Ibarz, Matthias Ritgen, Sebastian Boettcher, Kathryn Humphrey, Mark Dixon, Carsten Utoft Niemann, Barbara Eichhorst, Rod A. Humerickhouse, Laura M. Fogliatto, Kirsten Fischer, Valentin Goede, Thomas J. Kipps, Sandra Robrecht, Anna-Maria Fink, Robert Weinkove, Mehrdad Mobasher, Maneesh Tandon, Stephen Opat, Jasmin Bahlo, Simon Warburton, Anton W. Langerak, Karl Anton Kreuzer, Olga Samoylova, Eugen Tausch, Othman Al-Sawaf, Clemens M. Wendtner

المساهمون: Immunology

المصدر: New England Journal of Medicine, 380(23), 2225-2236. Massachussetts Medical Society

مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Venetoclax, Chronic lymphocytic leukemia, General Medicine, 030204 cardiovascular system & hematology, medicine.disease, 03 medical and health sciences, Leukemia, chemistry.chemical_compound, 0302 clinical medicine, chemistry, immune system diseases, Obinutuzumab, hemic and lymphatic diseases, Internal medicine, Monoclonal, medicine, Acalabrutinib, In patient, 030212 general & internal medicine, Progression-free survival, business, neoplasms

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a009eaf858ef618e22f00b57261c9ef
https://pure.eur.nl/en/publications/c6ed4f08-56f6-4380-b8cd-eaf857cf6cbf

المؤلفون: Mels Hoogendoorn, Ellen van der Spek, Clemens Mellink, Fransien Croon-de Boer, Julie Dubois, Shulamiet Wittebol, Mehrdad Mobasher, Sanne H. Tonino, Arnon P. Kater, Mark-David Levin, John Schreurs, Cecile Idink, Hein Visser, Yvette van Norden, Sabina Kersting, L. M. Evers, Johan A. Dobber

المساهمون: Hematology, Experimental Immunology, Clinical Haematology, CCA - Cancer Treatment and Quality of Life, Human Genetics

المصدر: Blood advances, 2(24), 3566-3571. American Society of Hematology

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, medicine.medical_specialty, Neoplasm, Residual, Randomization, Clinical Trials and Observations, Chronic lymphocytic leukemia, Population, Antineoplastic Agents, Antibodies, Monoclonal, Humanized, Drug Administration Schedule, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Risk Factors, Obinutuzumab, hemic and lymphatic diseases, Internal medicine, medicine, Humans, education, Aged, Sulfonamides, education.field_of_study, business.industry, Venetoclax, Remission Induction, Hematology, Middle Aged, Bridged Bicyclo Compounds, Heterocyclic, medicine.disease, Leukemia, Lymphocytic, Chronic, B-Cell, Minimal residual disease, body regions, Tumor lysis syndrome, 030104 developmental biology, chemistry, 030220 oncology & carcinogenesis, Monoclonal, Drug Therapy, Combination, Female, Tumor Lysis Syndrome, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cfc81aa3a7833eaaf846c029226045c
https://doi.org/10.1182/bloodadvances.2018019422

المؤلفون: Mark Dixon, Maneesh Tandon, C. Utoft Niemann, Liliya Sivcheva, Karl-Anton Kreuzer, Kathryn Humphrey, Laura M. Fogliatto, Simon Warburton, Sue Robinson, Anthonie Willem Langerak, C M Wendtner, Eugen Tausch, Barbara Eichhorst, Anna Marina Liberati, Robert Weinkove, Sandra Robrecht, Stephan Stilgenbauer, Kirsten Fischer, Javier Pinilla-Ibarz, Mehrdad Mobasher, M. Porro Lurà, Matthias Ritgen, Valentin Goede, Thomas J. Kipps, William Schary, Sebastian Boettcher, Michael Hallek, K. Le Dû, Stephen Opat, Othman Al-Sawaf, A. M. Fink, Jasmin Bahlo, Olga Samoylova

المصدر: Hematological Oncology. 37:82-84

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, Venetoclax, Hematology, General Medicine, Minimal Residual Disease Negativity, chemistry.chemical_compound, Fixed duration, chemistry, Obinutuzumab, Internal medicine, medicine, In patient, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::c6058960fee67ca2d46c10b3b69c4a09
https://doi.org/10.1002/hon.52_2629

المؤلفون: Jaime R. Merchan, Jason J. Luke, James W. Janc, Thomas U. Marron, Kristen A. Marrone, Jeffrey A. Sosman, Craig M. Hill, Suresh Mahabhashyam, Brett G.M. Hughes, Jenny A. Rudnick, Abhishek Tripathi, Igor Puzanov, Richard K. Miller, Shenshen Hu, Mehrdad Mobasher

المصدر: Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)

مصطلحات موضوعية: Pharmacology, Cancer Research, Cellular immunity, biology, business.industry, medicine.medical_treatment, Immunology, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Cancer, Pembrolizumab, Immunotherapy, CD38, medicine.disease, medicine.anatomical_structure, Oncology, biology.protein, medicine, Cancer research, Molecular Medicine, Immunology and Allergy, Immunohistochemistry, Antibody, business, RC254-282, B cell

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d213e12f8945eee821bbde1c6d39819a
https://doi.org/10.1136/jitc-2021-sitc2021.701

المؤلفون: Michael S. Khodadoust, Suresh Mahabhashyam, Tatyana Feldman, Mehrdad Mobasher, Andrew Hotson, Steven M. Horwitz, Costas K. Yannakou, Amit Khot, Youn H. Kim, Dok Hyun Yoon, Ryan A. Wilcox, Neha Mehta-Shah, Richard A. Miller, Dejan Radeski, Joseph J. Buggy, James W. Janc, Craig M. Hill, Brian Munneke, Won Seog Kim

المصدر: Blood. 136:19-20

مصطلحات موضوعية: medicine.medical_specialty, Horizon Pharma, Tcr signaling, business.industry, Early signs, Immunology, Cell Biology, Hematology, medicine.disease, Biochemistry, Peripheral blood, Family medicine, Interleukin-2-Inducible T-Cell Kinase, Medicine, T-cell lymphoma, Current employment, In patient, business, health care economics and organizations

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::bc7c0c0ca4052c0d9ba4748e934fa01f
https://doi.org/10.1182/blood-2020-137782

المؤلفون: Kathryn Humphrey, Maria Verdugo, Peter Hillmen, Thomas J. Kipps, Ian W. Flinn, Kerry A. Rogers, Mehrdad Mobasher, John G. Gribben, Loic Ysebaert, Gerard Lozanski, Daniela Soriano Pignataro, Richard R. Furman, Martin J. S. Dyer, Swaminathan P. Iyer, Anne Quillet-Mary, Yanwen Jiang, William G. Wierda, Huang Huang, Michael B. Maris, Harriet S. Walter, Christian Klein

المساهمون: Queen Mary University of London (QMUL), School of Computing [Leeds], University of Leeds, Department of Hematology, St. James's Institute of Oncology, Centre de Recherches en Cancérologie de Toulouse (CRCT), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Laboratoire d'Hématologie [Purpan], Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-CHU Toulouse [Toulouse]-Hôpital Purpan [Toulouse], CHU Toulouse [Toulouse], AbbVie Inc. [North Chicago, Illinois, USA], Laboratoire Univers et Théories (LUTH (UMR_8102)), Institut national des sciences de l'Univers (INSU - CNRS)-Observatoire de Paris, Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Diderot - Paris 7 (UPD7), Ohio State University [Columbus] (OSU), PSL Research University (PSL)-PSL Research University (PSL)-Université Paris Diderot - Paris 7 (UPD7)-Centre National de la Recherche Scientifique (CNRS)

المصدر: Blood
Blood, American Society of Hematology, 2019, 133 (26), pp.2765-2775. ⟨10.1182/blood-2019-01-896290⟩

مصطلحات موضوعية: 0301 basic medicine, Adult, Male, medicine.medical_specialty, Maximum Tolerated Dose, Chronic lymphocytic leukemia, [SDV]Life Sciences [q-bio], Immunology, [SDV.CAN]Life Sciences [q-bio]/Cancer, Neutropenia, Antibodies, Monoclonal, Humanized, Biochemistry, Gastroenterology, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Refractory, Obinutuzumab, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Medicine, Humans, ComputingMilieux_MISCELLANEOUS, Aged, Aged, 80 and over, Sulfonamides, Venetoclax, business.industry, [SDV.MHEP.HEM]Life Sciences [q-bio]/Human health and pathology/Hematology, Cell Biology, Hematology, Middle Aged, medicine.disease, Bridged Bicyclo Compounds, Heterocyclic, Minimal residual disease, Leukemia, Lymphocytic, Chronic, B-Cell, 3. Good health, Tumor lysis syndrome, 030104 developmental biology, chemistry, Tolerability, 030220 oncology & carcinogenesis, Female, Neoplasm Recurrence, Local, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c6a42d530e3e256cd7d06e6bf8944ef
https://hal.archives-ouvertes.fr/hal-02324667

المؤلفون: Steven Coutre, Johannes Schetelig, Sebastian Böttcher, Mehrdad Mobasher, Sari H. Enschede, Michael Hallek, Rod A. Humerickhouse, Talha Munir, John F. Seymour, Soham D. Puvvada, Maria Verdugo, Brenda Chyla, Andrew W. Roberts, Wojciech Jurczak, Gary Gordon, Clemens M. Wendtner, Ming Zhu, Barbara Eichhorst, Elisa Cerri, Monali Desai, William G. Wierda, Stephen P. Mulligan, Stephan Stilgenbauer

المصدر: The Lancet Oncology. 17:768-778

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, medicine.medical_specialty, Population, Antineoplastic Agents, Neutropenia, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, medicine, Humans, education, Survival rate, Aged, Neoplasm Staging, Aged, 80 and over, Salvage Therapy, Sulfonamides, education.field_of_study, business.industry, Venetoclax, Middle Aged, Bridged Bicyclo Compounds, Heterocyclic, Prognosis, medicine.disease, Leukemia, Lymphocytic, Chronic, B-Cell, Fludarabine, Surgery, Survival Rate, 030104 developmental biology, Oncology, chemistry, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Alemtuzumab, Female, Chromosome Deletion, Neoplasm Recurrence, Local, Refractory Chronic Lymphocytic Leukemia, business, Febrile neutropenia, Chromosomes, Human, Pair 17, Follow-Up Studies, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0974f66c3c29a8c4db17b3947ba47bd5
https://doi.org/10.1016/s1470-2045(16)30019-5

المؤلفون: Martin H. Voss, Stephen Willingham, Richard A. Miller, Jaime R. Merchan, Lawrence Fong, Andrew Hotson, Brett G.M. Hughes, Saby George, Brian Munneke, Mehrdad Mobasher, Michael Chu

المصدر: Journal of Clinical Oncology. 38:5025-5025

مصطلحات موضوعية: Cancer Research, Tumor microenvironment, CD68, business.industry, medicine.medical_treatment, Immunotherapy, Adenosine, Blockade, Oncology, Gene expression, Cancer research, medicine, Cell cancer, business, Gene, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::0e34da47d8a9879288cdea6c5fc13c3e
https://doi.org/10.1200/jco.2020.38.15_suppl.5025

المؤلفون: Asher Chanan-Khan, Jeffrey A. Jones, Danelle F James, Ai Ni, Guan Xing, Neil E. Kay, Mehrdad Mobasher, Anil Londhe, John C. Byrd, Richard R. Furman, John F. Seymour, Yeung-Chul Mun, Pankaj Bhargava, Jacob D. Soumerai, Lucille Ferrante, Mohamed Darif, Vijay Reddy, Angela Howes, Tait D. Shanafelt, Peter Hillmen, Thomas Stark, Jeffrey P. Sharman, Kari G. Rabe, Lyndah Dreiling, Andrew D. Zelenetz

المصدر: Lancet Haematol

مصطلحات موضوعية: Oncology, Male, medicine.medical_specialty, Databases, Factual, Antineoplastic Agents, Ofatumumab, Article, 03 medical and health sciences, chemistry.chemical_compound, Hemoglobins, 0302 clinical medicine, Piperidines, Chemoimmunotherapy, Risk Factors, Internal medicine, medicine, Humans, Survival rate, Proportional Hazards Models, Quinazolinones, Randomized Controlled Trials as Topic, Retrospective Studies, Sulfonamides, L-Lactate Dehydrogenase, Venetoclax, business.industry, Adenine, Retrospective cohort study, Hematology, Middle Aged, Bridged Bicyclo Compounds, Heterocyclic, Prognosis, Leukemia, Lymphocytic, Chronic, B-Cell, Survival Rate, Pyrimidines, chemistry, Purines, 030220 oncology & carcinogenesis, Ibrutinib, Pyrazoles, Female, Immunotherapy, Idelalisib, business, beta 2-Microglobulin, 030215 immunology, Cohort study

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a39ae66eed9900db021e61cb4943dcee
https://pubmed.ncbi.nlm.nih.gov/31244475

المؤلفون: Luciano J. Costa, Andrew D. Zelenetz, Mehrdad Mobasher, Charlotte Vignal, Günter Fingerle-Rowson, Kirsten Mundt, Deniz Sahin, Luis Fayad, Andrew M. Evens, Andres Forero-Torres, Thomas Sandmann, Alberto Bessudo, Christopher R. Flowers, Ian W. Flinn, Jeff P. Sharman, Mark S. Kaminski, Kevin Kelly, Lowell Inhorn

مصطلحات موضوعية: Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, Vincristine, Cyclophosphamide, CHOP, Antibodies, Monoclonal, Humanized, Article, 03 medical and health sciences, chemistry.chemical_compound, Young Adult, 0302 clinical medicine, immune system diseases, Prednisone, Obinutuzumab, hemic and lymphatic diseases, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, polycyclic compounds, medicine, Humans, Doxorubicin, Drug Interactions, Aged, Neoplasm Staging, Aged, 80 and over, business.industry, Hematology, Middle Aged, medicine.disease, Prognosis, Lymphoma, Treatment Outcome, chemistry, 030220 oncology & carcinogenesis, Female, Lymphoma, Large B-Cell, Diffuse, Drug Monitoring, business, Diffuse large B-cell lymphoma, 030215 immunology, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e82eac73550566d53fe3dffa391519ee
https://europepmc.org/articles/PMC6445782/